Entrada Therapeutics, Inc. — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entrada Therapeutics, Inc. (TRDA)
CIK: 0001689375
Period of Report: 2021-10-28

Reporting Person: Thistle Mary (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-28	Stock Option (Right to Buy)	$20	A	11918	Acquired	2031-10-28	Common stock (11918)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of October 28, 2021 (the "Vesting Start Date") or (ii) the Issuer's next annual meeting of stockholders.